SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-17-000059
Filing Date
2017-08-14
Accepted
2017-08-14 17:29:08
Documents
63
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20170630x10q.htm 10-Q 1165122
2 EXHIBIT 31.1 gale20170630ex311.htm EX-31.1 8934
3 EXHIBIT 32.1 gale20170630ex321.htm EX-32.1 7765
10 q22017pipeline3.jpg GRAPHIC 63494
  Complete submission text file 0001390478-17-000059.txt   6122088

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gale-20170630.xml EX-101.INS 1204280
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20170630.xsd EX-101.SCH 54152
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20170630_cal.xml EX-101.CAL 71922
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20170630_def.xml EX-101.DEF 224513
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20170630_lab.xml EX-101.LAB 639218
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20170630_pre.xml EX-101.PRE 374564
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 171031778
SIC: 2834 Pharmaceutical Preparations